Home/Stocks/Financials

CMC Markets PLC

CMCX.L·Financials·Market Cap £1.9b
Rank #27 of 280
Quantitative Model · 280 Stocks Analysed
£6.78
+126.76% YTD
52W: £2.03 - £7.87

Factor Analysis Summary

Editorial assessment generated from CMC Markets PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, CMC Markets PLC (CMCX.L) currently holds an overall rank of #27 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation; solvency (debt/equity 0.3), where it demonstrates a sound financial footing with manageable debt levels and adequate interest coverage; and liquidity, where it demonstrates solid trading liquidity that should accommodate most institutional order sizes.

Areas requiring attention include asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet, as well as valuation (P/E 24.6, dividend yield 4.0%), where valuation offers limited margin of safety at current price levels.

Within the Financials sector, CMC Markets PLC sits at composite rank #27, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

With a composite rank in the top decile (better than 91% of the universe) and 1 factor in the top quartile, CMC Markets PLC presents a broadly attractive multi-factor profile, led by market trading and tempered only by asset efficiency.

Strongest Factors

  • Market Trading — Rank 34/280 (top quartile)
  • Solvency — Rank 99/280 (above average)
  • Liquidity — Rank 107/280 (above average)

Weakest Factors

  • Asset Efficiency — Rank 187/280 (below average)
  • Valuation — Rank 149/280 (middle of the pack)

Score Analysis

CMC Markets PLC is ranked #27 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

121/280
Average Score
Liquidity
Good107/280
Valuation
Fair149/280
Profitability
Fair124/280
Solvency
Good99/280
Asset Efficiency
Weak187/280
Mkt Trading
Excellent34/280
Technical
Fair144/280

1. Liquidity

Score: 107/280

How liquid is CMCX and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio1.75x
Range: N/ARank 95/280
–
TTM Operating Cash Flow-0.02x
Range: N/ARank 221/280
–
Liquidity Coverage RatioN/A
Range: 100-150
✗
Intangible Asset Ratio0.04x
Range: 10 - 30Rank 98/280
–
Cash-to-Debt Ratio2.23x
Range: N/ARank 39/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
1.75x
Sector: N/A

Overall Liquidity Rank

Rank within universe#107/280
Best (1)Worst (280)

2. Valuation

Score: 149/280

Is CMCX undervalued compared to its peers and fair value metrics?

4/7
valuation criteria met
✓
FY27e P/E10.1x
Range: 8x - 18xRank 65/280
✓
FY26e P/E11.1x
Range: 8x - 18xRank 61/280
✓
FY27e Net Div Yld (%)3.78%
Range: 3.0 - 8.0Rank 110/280
✓
Div Payout Ratio49.96%
Range: 30 - 55Rank 100/280
–
Current EV/EBITDA5.9x
Range: N/ARank 66/280
✗
Current P/TBV2.29x
Range: 0.8x - 2.0xRank 136/280
✗
Current P/B2.10x
Range: 0.8x - 2.0xRank 173/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
24.6x
FY26e P/E
Forward estimate
11.1x
FY27e P/E
Forward estimate
10.1x
Current P/B
Price-to-Book
2.10x
Current P/TBV
Tangible Book Value
2.29x
Current EV/EBITDA
Enterprise Value
5.9x
FY26e EV/EBITDA
Forward estimate
6.3x
FY27e EV/EBITDA
Forward estimate
6.3x

Dividend

CMCX pays a dividend yield of 4.02%.

Current Yield
4.02%
FY27e Net Div Yield
3.78%
FY26e Gross DPS
0.147
FY27e Gross DPS
0.256

Dividend Per Share Forecast

3. Profitability

Score: 124/280

How profitable is CMCX relative to its peers?

1/7
profitability criteria met
✓
TTM Profit Margin19.1%
Range: 15 - 30Rank 114/280
–
T12 FCF Margin-0.1%
Range: N/ARank 218/280
✗
FY27e RoE25.5%
Range: 10 - 16Rank 54/280
✗
FY26 EPS Growth118.6%
Range: 8 - 15Rank 16/280
✗
FY27e EPS Growth140.8%
Range: 6 - 12Rank 19/280
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
19.1%
Current RoCE
17.0%
FY27e RoE
25.5%
T12 FCF Margin
-0.1%

EPS Growth

4. Solvency

Score: 99/280

How strong is CMCX's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.27x
Range: 0.5x - 1.5xRank 107/280
–
Interest Coverage RatioRank 53
Range: N/ARank 53/280
–
Net Leverage Ratio-1.28x
Range: N/ARank 11/280
–
Altman Z-Score (Manufacturing)6.38
Range: N/ARank 104/280
–
Z-Score (Non Manufacturing)Rank 142
Range: N/ARank 142/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.27x
Net Leverage Ratio
-1.28x
Interest Coverage
Rank 53
T12 FCF Margin
-0.1%

Altman Z-Score

6.38
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 187/280

How efficiently does CMCX deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.45x
Range: N/ARank 138/280
✗
TTM CAPEX/Sales3.4%
Range: 1 - 3Rank 118/280
–
Working Capital Turnover1.05x
Range: N/ARank 146/280
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#187/280
Best (1)Worst (280)

6. Market Trading

Score: 34/280

How liquid and actively traded is CMCX?

1/2
market trading criteria met
✗
Intraday Sentiment (%)98.0%
Range: 40 - 75Rank 6/280
–
10D-Avg v/s 3M-Avg Vol81%
Range: N/ARank 50/280
✓
Avg Directional Index 30D30.6
Range: 012 - 45Rank 28/280
–
Parabolic SAR601.09
Range: N/ARank 138/280
–
Stock Rating RankRank 50
Range: N/ARank 50/280
Market Cap
£1,897,148,839
Enterprise Value
£1,625,415,839

Trading Volume

7. Technical

Score: 144/280

What do the technical indicators say about CMCX?

0/5
technical criteria met
–
CMP v/s 52-WH-13.9%
£7.87£2.03
-13.9%CMP: £6.78
Range: N/ARank 160/280
–
CMP v/s 52-WL234.0%
£7.87£2.03
+234.0%CMP: £6.78
Range: N/ARank 280/280
–
RSI 14D44.3
044.3 - Bearish100
Range: N/ARank 50/280
–
MA50 - MA200Bullish
£4.88+2.15£7.02
Range: N/ARank 23/280
–
MACD Rank0.23
Golden Cross
MACD: 0.23
Range: N/ARank 100/280

RSI (14 Day)

44.3
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£7.02
200 SMA£4.88
SignalGolden Cross (Bullish)
MACD0.23

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does CMCX compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
CMCX#271071491249934144
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for CMC Markets PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.